NEW YORK, Jan. 3, 2024 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating potential claims related to the below-listed proposed mergers. Kuehn Law may seek additional disclosures or other relief on behalf of the shareholders of these companies. 

Kuehn Law, PLLC (PRNewsfoto/Kuehn Law, PLLC)

Kuehn Law is investigating whether the Boards of the below companies 1) acted to maximize shareholder value, 2) failed to disclose material information, and 3) conducted a fair process: 

  • Eagle Bulk Shipping Inc. (NYSE: EGLE)

Per the merger agreement, Eagle Bulk shareholders will get 2.6211 Star Bulk shares for each Eagle share, valuing each Eagle share at about $52.60. Post-merger, Star Bulk and Eagle shareholders will own roughly 71% and 29% of the merged company, respectively.

  • Icosavax, Inc. (Nasdaq: ICVX)

According to the agreement terms, AstraZeneca will, via a subsidiary, start a tender offer to purchase all outstanding shares of Icosavax for $15.00 per share in cash. Additionally, shareholders will receive a non-tradable contingent value right for up to $5.00 in cash.

  • Rain Oncology, Inc. (Nasdaq: RAIN)

Under the merger agreement, Pathos will buy Rain Oncology at $1.16 per share in cash, plus a non-tradeable CVR for potential extra cash payments up to $0.17 per share.

  • Alteryx, Inc. (NYSE: AYX)

Under the proposed transaction, Clearlake Capital Group and Insight Partners will acquire Alteryx for $48.25 in cash for each share of Class A or Class B common stock.

Why Your Participation Matters:

As a shareholder your voice matters, and by getting involved, you contribute to the integrity and fairness of the financial markets. Your investment. Your voice. Your future.

How to Get Involved:

Kuehn Law is dedicated to safeguarding shareholder interests. Concerned shareholders are encouraged to contact Justin Kuehn, Esq., at justin@kuehn.law or call (833) 672-0814. Kuehn Law covers all case costs and does not charge its investor clients.  Shareholders are advised to act promptly, as legal rights may be time-sensitive.

Attorney advertising. Prior results do not guarantee similar outcomes.

Contacts:
Kuehn Law, PLLC
Justin Kuehn, Esq.
53 Hill Street, Suite 605
Southampton, NY 11968
justin@kuehn.law
(833) 672-0814

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/kuehn-law-encourages-egle-icvx-rain-and-ayx-investors-to-contact-law-firm-302025655.html

SOURCE Kuehn Law, PLLC

Copyright 2024 PR Newswire

Icosavax (NASDAQ:ICVX)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Icosavax Charts.
Icosavax (NASDAQ:ICVX)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Icosavax Charts.